- ... al 2017 ]. Modifying inflammatory responses. Regadenoson is an adenosine A2A receptor agonist that modifies natural killer cell activity and ... of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson. Blood. 2013; 121 :3329–34. [ PMC ...
1 results